Company / Net Income
Krystal Biotech, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$204.8M
FY2025
5-year range
-$140.0M / $204.8M
FY2021-FY2025
Trend
+129.7%
vs FY2024
Sector context
#36 of 216
Health Care
What the data says
Krystal Biotech, Inc.'s net income of $205M is higher than 83% of companies in the Health Care sector (FY2025). Net Income has increased for 3 consecutive years, from -$140M in FY2022 to $205M in FY2025.
Based on SEC 10-K filings.
$205M in FY2025. Top quartile in the Health Care sector.
Improved from $11M to $205M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 216This company $204.8M Sector average $454.3M
▼
-54.9% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 129.7% year-over-year.
- Ranks #36 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $204.8M | +129.7% |
| FY2024 | $89.2M | +715.6% |
| FY2023 | $10.9M | +107.8% |
| FY2022 | -$140.0M | -101.2% |
| FY2021 | -$69.6M | -116.3% |
| FY2020 | -$32.2M | -68.5% |
| FY2019 | -$19.1M | -75.3% |
| FY2018 | -$10.9M | -37.5% |
| FY2017 | -$7.9M | -588.7% |
| FY2016 | -$1.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026